General MedicationsORALGeneric
KANTREX
KANAMYCIN SULFATE
Standard Dose
EQ 500MG BASE
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary
Approval overview KANTREX is listed in Drugs@FDA under application 062726 (ANDA).
Marketing status: Discontinued Active ingredient KANAMYCIN SULFATE Form and strength CAPSULE;ORAL - EQ 500MG BASE Sponsor APOTHECON Submission history Latest submission status date: 1998-05-04 00:00:00.
Structured Monograph
Clinical summary
Approval overview KANTREX is listed in Drugs@FDA under application 062726 (ANDA). Marketing status: Discontinued Active ingredient KANAMYCIN SULFATE Form and strength CAPSULE;ORAL - EQ 500MG BASE Sponsor APOTHECON Submission history Latest submission status date: 1998-05-04 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
Interaction Notes
- No interaction notes stored yet.